GlassScriptPhysician profile
Ian M Thompson
NPI 1033126933
$994.06
in general payments reported to CMS, 2019-2025
12 companies · $301 in 2025
The $301 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2022: $102 · 2023: $165 · 2024: $280 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $360.83 | 2024-2025 | |
| Fujifilm Healthcare Americas Corporation | $142.95 | 2023 | Arietta Precision |
| Bluewind Medical | $113.26 | 2024 | Revi |
| Boston Scientific Corporation | $101.99 | 2022 | |
| Endo Pharmaceuticals INC. | $84.99 | 2019 | |
| Smith+Nephew, INC. | $67.90 | 2025 | Stravix Pl, Stravix |
| Valencia Technologies Corporation | $38.59 | 2025 | Ecoin Device Kit |
| Telix Pharmaceuticals | $22.15 | 2023 | Illuccix |
| Neotract INC. | $18.16 | 2019 | |
| Mission Pharmacal Company | $15.88 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $15.48 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.